Novartis powers drug delivery specialist to $40M funding round BD pitches for COVID-19 vaccine market by showing prefilled syringes cope with deep cold storage SynAgile takes on debt to wrap up midphase trial of drug delivery dental retainer Intract signs up another oral monoclonal antibody partner GlaxoSmithKline's long-acting HIV drug nabs FDA priority review as a preventative option Featured Story | By Nick Paul Taylor Credence MedSystems has topped up its bank account again. With Novartis coming on board as an investor, the California-based company has reeled in $39.9 million to boost production of injectable drug delivery systems. read more |
| |
|---|
|
| | Webinar: New ctDNA Data in Response Monitoring Thursday, October 14 | 11am ET / 8am PT Discover improvements to clinical trial design with Signatera including: identifying early relapsers, enriching for patients potentially most likely to respond to therapy, accelerating time to trial readout, predicting clinical outcomes as early as 6 weeks into treatment. Learn More. |
Top Stories By Nick Paul Taylor BD has positioned itself to unlock a new COVID-19 vaccine opportunity by showing its glass prefilled syringes are suitable for use with mRNA shots that need storing at ultralow temperatures. read more By Nick Paul Taylor The limitations of orally delivered levodopa have inspired a range of novel formulations designed to provide more constant levels of the drug. SynAgile has put its own spin on the molecule with a drug delivery dental retainer—and has secured debt financing to take it through phase 2. read more By Nick Paul Taylor Intract Pharma has landed another oral antibody delivery partnership. Bio-Thera Solutions is the latest drug developer to strike a deal for Intract’s technology, securing itself the right to use the oral delivery system with a single undisclosed monoclonal antibody. read more By Kevin Dunleavy With a priority review designation from the FDA, GlaxoSmithKline has moved a step closer to a potential approval of cabotegravir as the first long-acting therapy for HIV pre-exposure prophylaxis (PrEP). The FDA has set a deadline for the review by January 24. read more Resources Sponsored by: WCG Every biopharma sponsor faces the challenge of initiating, running and closing trials on time, but oncology studies pose several unique hurdles. Sponsored By: Unlearn AI Read Unlearn’s whitepaper to learn about how novel trial designs with Digital Twins enable more efficient clinical trials, with higher power and smaller required sample sizes. Sponsored by: Patheon by Thermo Fisher Scientific Choose the right AAV platform for your viral vector-based therapy Sponsored by: XIFIN inc. Download the Value of Precision Medicine Informatics (PMI) Initiatives report to learn about the technology, data types, and the value derived from more than 100 PMI initiatives. Sponsored by: EVERSANA Today’s economics do not allow manufactures to keep making decisions in an antiquated way. They need to challenge tradition & deliver faster, cheaper, successful launches. Learn how. Sponsored by: Thermo Fisher Scientific Thermo Fisher Scientific introduces a new NK cell culture medium designed to support feeder-free, high-yield growth for cell therapy applications. Sponsored by: Blue Matter This white paper provides a concise overview of the trends currently shaping the market access environment in Europe, as well as the implications for biopharma companies. Sponsored by: Box Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization. Sponsored By: Remarque Systems Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Announcing the 9th International mRNA Health Conference November 09-10, 2021 | Mercure MOA Berlin & Online Let A Digital Sherpa Uncomplicate The Path for Patients Recorded On September 15, 2021 Sea-dumped chemical weapons: environmental risk, occupational hazard September 22, 2021 Clinical Quality Oversight Forum September 27-29, 2021 | Philadelphia, PA The MedTech Conference 2021 September 27 - 30, 2021 Digital Pharma East September 28-30, 2021 | Pennsylvania Convention Center, Philadelphia | October 5-8, 2021 | Virtual Event Introduction to Structure Elucidation in Drug Development Sep 29, 2021 Fierce Pharma Marketing Awards September 29, 2021 | Philadelphia, PA Pharma PR & Communications Summit October 4-5, 2021 | Jersey City, NJ Virtual U.S. Healthcare Compliance Certificate Program October 11 – 14, 2021 Fierce Biotech Cell & Gene Therapy October 19, 2021 | Virtual Event TMF Summit October 25-27, 2021 | New Orleans, LA Fierce Health Payer Summit Virtual Event | October 26, 2021 Diversity, Equity, & Inclusion Summit November 9–10, 2021 | Virtual Event Drug Development Boot Camp® 2021 Onsite and VIRTUAL in real time November 17-18, 2021 | Register now! Pre-Boot Camp preparation is now available. | 